Remove Hospital Remove Pacemaker Remove Technology
article thumbnail

Early experience with a novel transapical transcatheter aortic valve system in patients with severe aortic stenosis: a prospective, multicenter study

Frontiers in Cardiovascular Medicine

ObjectivesRegistered, prospective, multicenter study of the short-term clinical outcomes of a novel transcatheter aortic valve system (Xcor system, Saint Medical Technology, Inc., Procedural, in-hospital, and follow-up clinical outcomes were evaluated after procedures.ResultsThe average age of the 130 patients was 71.24.4

article thumbnail

DAIC's Top 10 for June

DAIC

Landmark Clinical Study in The Lancet Finds New AI Technology Can Predict Cardiac Events Due to Coronary Inflammation at Least 10 Years in Advance 3. In Memoriam: Prolific Philanthropist Ann Lurie, Namesake of the Ann and Robert H Lurie Children’s Hospital of Chicago 5.

article thumbnail

Study Shows Medtronic ICM Accurately Predicts Risk Thresholds for AFib Patients Using AI

DAIC

The data supports the conclusion that the AI-based analytics from the ICMs provide valuable information, particularly for those at a higher risk of an AF-related hospitalization, clinic visit, or therapeutic intervention. The first-of-its-kind DEFINE AFib study leveraged a unique design that engaged patients from the very beginning.

AFIB 52
article thumbnail

Medtronic Receives CE Mark for its Next Generation Micra Leadless Pacing Systems

DAIC

milla1cf Fri, 01/05/2024 - 11:42 June 5, 2024 — Medtronic , a global leader in healthcare technology, today announced it has received CE (Conformité Européenne) Mark for its Micra AV2 and Micra VR2 , the next generation of its industry-leading miniature, leadless pacemakers. 3 This CE Mark milestone follows U.S. Kowal, M.D.,

article thumbnail

Editorial: Response to cardiac resynchronization therapy

Frontiers in Cardiovascular Medicine

Since the implantation of the first pacemakers in the 1960s, rapid advancements in biomedical technologies have led to the development of Cardiac Resynchronization Therapy (CRT) in the 1990s. 1,2) Moreover, now evidence on CRT upgrade with hard outcome is also available for patients with HFrEF and wide, paced QRS (3).

article thumbnail

Global Differences in Managing Patients with Aortic Valve Disease

Society of Thoracic Surgeons - Congenital

On the other hand, high-income countries have adequate and widespread healthcare facilities of the highest technological advancement. Over the past three decades, these facilities have become highly technological and with high scientific advancement. Patients in these countries are covered by national healthcare insurance.

article thumbnail

History & Future of Cardiac Remote Patient Monitoring

Vector Remote

History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.